Published in J Nucl Med on August 01, 1978
Studies of uptake of the bretylium analogue, iodobenzyltrimethylammonium iodide, by non-primate, monkey and human hearts. Br J Clin Pharmacol (1979) 0.81
Scintigraphic localization of pheochromocytoma. N Engl J Med (1981) 1.88
Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation (1990) 1.78
Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med (1980) 1.62
A prospective investigation of pulmonary embolism in women and men. JAMA (1992) 1.52
Technical cost of CT examinations. Radiology (2001) 1.50
Iodine-125-MIBG to treat neuroblastoma: preliminary report. J Nucl Med (1990) 1.48
In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol (1996) 1.45
Evaluation of intravascular low-osmolality contrast agents. Clin Pharm (1986) 1.45
Solitary abnormalities in bone scans of patients with extraosseous malignancies. Radiology (1976) 1.44
Can academic radiology departments become more efficient and cost less? Radiology (1998) 1.40
Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med (1981) 1.31
Early detection of stress fractures using 99mTc-polyphosphate. Radiology (1976) 1.31
Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation (1998) 1.29
Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med (1981) 1.21
Salivary gland accumulation of meta-[131I]iodobenzylguanidine. J Nucl Med (1984) 1.21
The effect of ibuprofen on accumulation of indium-111-labeled platelets and leukocytes in experimental myocardial infarction. Circulation (1982) 1.21
Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med (1987) 1.18
Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells. Mol Pharmacol (1984) 1.15
Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. AJR Am J Roentgenol (1991) 1.13
Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT). J Nucl Med (1984) 1.12
Radiopharmaceutical treatment of malignant pheochromocytoma. J Nucl Med (1984) 1.11
Coded-aperture imaging of the heart. J Nucl Med (1980) 1.11
Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J Nucl Med (1990) 1.07
Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine. Ann Intern Med (1981) 1.06
Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies. Am J Physiol Imaging (1986) 1.03
Assessment of cardiac sympathetic nerve integrity with positron emission tomography. Nucl Med Biol (2001) 1.01
Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-11 hydroxyephedrine and positron emission tomography. Metabolism (1999) 1.01
Adrenal scintigraphy. Semin Nucl Med (1978) 0.99
Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication. J Nucl Med (1981) 0.98
[18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses. Synapse (1998) 0.98
Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med (1987) 0.98
PET imaging of human gliomas with ligands for the peripheral benzodiazepine binding site. Ann Neurol (1989) 0.97
Assessment of hydroureteronephrosis in children using diuretic radionuclide urography. J Urol (1980) 0.97
PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med (1992) 0.97
Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol (1993) 0.97
Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy. J Am Coll Cardiol (1998) 0.96
The scintigraphic imaging of endocrine organs. Endocr Rev (1984) 0.95
Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med (1985) 0.94
The lymphatic system: diagnostic imaging studies. Radiology (1989) 0.93
Pitfalls in Tc99m polyphosphate skeletal imaging. Am J Roentgenol Radium Ther Nucl Med (1974) 0.89
Integrated diagnostics: proceedings from the 9th biennial symposium of the International Society for Strategic Studies in Radiology. Eur Radiol (2012) 0.89
Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience. J Nucl Biol Med (1992) 0.89
Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer. Cancer Res (1986) 0.89
In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J Nucl Med (1994) 0.89
Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol (1993) 0.89
Evaluation of sympathetic nerve terminals with [(11)C]epinephrine and [(11)C]hydroxyephedrine and positron emission tomography. Circulation (2000) 0.88
Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging. Radiographics (1993) 0.88
Myocardial kinetics of carbon-11-meta-hydroxyephedrine: retention mechanisms and effects of norepinephrine. J Nucl Med (1993) 0.88
High-dose doxorubicin: an exploration of the dose-response curve in human neoplasia. Cancer Treat Rep (1982) 0.88
Walk-through angina phenomenon demonstrated by graded exercise radionuclide ventriculography: possible coronary spasm mechanisms. Am Heart J (1982) 0.87
Clinical comparison of cardiac blood pool visualization with technetium-99m red blood cells labeled in vivo and with technetium-99m human serum albumin. J Nucl Med (1978) 0.87
The importance of adequate exercise in the detection of coronary heart disease by radionuclide ventriculography. J Nucl Med (1980) 0.86
Mouse brain distribution of a carbon-11 labeled vesamicol derivative: presynaptic marker of cholinergic neurons. Life Sci (1990) 0.86
Quantitative hepatic arterial perfusion scintigraphy and starch microspheres in cancer chemotherapy. J Nucl Med (1983) 0.86
In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography. J Cereb Blood Flow Metab (1992) 0.85
High yield synthesis of high specific activity R-(-)-[11C]epinephrine for routine PET studies in humans. Nucl Med Biol (1993) 0.85
Standards of radiology practice: an approach to development. Radiology (1989) 0.85
Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol. J Med Chem (1996) 0.84
Skeletal scintigraphy following incidental trauma. Radiology (1979) 0.84
The use of a vasoconstrictor to improve tumour blood flow in intra-arterial chemotherapy: preliminary report. Nucl Med Commun (1985) 0.84
Portrayal of pheochromocytoma and normal human adrenal medulla by m-[123I]iodobenzylguanidine: concise communication. J Nucl Med (1984) 0.84
Technetium-99m labeled agents for skeletal imaging. CRC Crit Rev Clin Radiol Nucl Med (1976) 0.84
Tomographic thyroid scintigraphy: comparison with standard pinhole imaging: concise communication. J Nucl Med (1981) 0.83
Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma. J Nucl Biol Med (1992) 0.83
Impact of radionuclide techniques on evaluation of patients with ischemic heart disease. J Am Coll Cardiol (1983) 0.83
Making global telemedicine practical and affordable: demonstrations from the Middle East. AJR Am J Roentgenol (1994) 0.83
Abnormal radionuclide deposition patterns adjacent to focal skeletal lesions. Radiology (1975) 0.83
Scintigraphic characterization of amyloid cardiomyopathy. Clin Nucl Med (1985) 0.82
Synthesis and in vivo evaluation of a 99m/99Tc-DADT-benzovesamicol: a potential marker for cholinergic neurons. Nucl Med Biol (1994) 0.82
Synthesis of the 123I- and 125I-labeled cholinergic nerve marker (-)-5-iodobenzovesamicol. Nucl Med Biol (1993) 0.82
Synthesis and preliminary evaluation of [11C]-(-)-phenylephrine as a functional heart neuronal PET agent. Nucl Med Biol (1996) 0.82
False negative bone scans in neuroblastoma metastatic to the ends of long bones. AJR Am J Roentgenol (1978) 0.81
Synthesis and evaluation of [123I]-iodo-PK11195 for mapping peripheral-type benzodiazepine receptors (omega 3) in heart. Nucl Med Biol (1996) 0.81
Diuretic radionuclide urography: a non-invasive method for evaluating nephroureteral dilatation. J Urol (1979) 0.81
Myocardial kinetics of carbon-11-epinephrine in the isolated working rat heart. J Nucl Med (1997) 0.80
Iodine-131: optimal therapy for hyperthyroidism in children and adolescents? J Nucl Med (1979) 0.80
Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine. J Nucl Med (1986) 0.80
African American adolescents: adaptational processes and socioeconomic diversity in behavioural outcomes. J Adolesc (1988) 0.80
Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism. J Nucl Med (1979) 0.80
Diagnosis of obstruction in experimental hydroureteronephrosis. Urology (1981) 0.80
Synthesis of a high specific activity 125I-labeled analog of PK 11195, potential agent for SPECT imaging of the peripheral benzodiazepine binding site. Int J Rad Appl Instrum B (1989) 0.80
Clinical evaluation of carbon-11-phenylephrine: MAO-sensitive marker of cardiac sympathetic neurons. J Nucl Med (1996) 0.80
Adrenal medulla imaging agents: a structure-distribution relationship study of radiolabeled aralkylguanidines. J Med Chem (1984) 0.80
Treatment of massive acute pulmonary embolism. The use of low doses of intrapulmonary arterial streptokinase combined with full doses of systemic heparin. Chest (1988) 0.80
Adrenal imaging agents: rationale, synthesis, formulation and, metabolism. Semin Nucl Med (1978) 0.79
Metaiodobenzylguanidine [131I] scintigraphy detects impaired myocardial sympathetic neuronal transport function of canine mechanical-overload heart failure. Circ Res (1987) 0.79
Imaging the adrenal medulla with an I-131-labeled antiadrenergic agent. J Nucl Med (1979) 0.79
Development of a kit-form analog of metaiodobenzylguanidine. J Nucl Med (1986) 0.79
Treatment of neuroblastoma with [125I]metaiodobenzylguanidine. J Nucl Biol Med (1992) 0.79